Work

High-dose carmustine, thiotepa and etoposide followed by autologous bone marrow rescue for the treatment of high risk central nervous system tumors

Year: 2000

Type: article

Source: Bone Marrow Transplantation

DOI: 10.1038/sj.bmt.1702475

Authors: V Papadakis, IJ Dunkel, LD Cramer, E Kramer, E Papadopoulos, S Goldman, RJ Packer, M Willoughby, D Baker, J Garvin, S Strandjord, P Coccia, AM Kaplan, M Klemperer, JL Finlay

Institutions: Memorial Sloan Kettering Cancer Center, Cooper University Hospital, Rowan University, University of Chicago, Children's National, Princess Margaret Hospital for Children, NewYork–Presbyterian Hospital, East Carolina University, University of Nebraska Medical Center, Phoenix Children's Hospital, Johns Hopkins University, Johns Hopkins All Children's Hospital, NYU Langone Health, New York University

Language: English

Topic: Glioma Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2088939712

FWCI: 0.592

Cites: 38

Cited by: 43

Related to: 10